WallStSmart

CubeSmart (CUBE)vsSabra Healthcare REIT Inc (SBRA)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

CubeSmart generates 32% more annual revenue ($1.14B vs $863.77M). CUBE leads profitability with a 29.3% profit margin vs 7.6%. SBRA appears more attractively valued with a PEG of 5.28. CUBE earns a higher WallStSmart Score of 56/100 (C).

CUBE

Buy

56

out of 100

Grade: C

Growth: 4.7Profit: 8.0Value: 5.3Quality: 3.0
Piotroski: 2/9Altman Z: 0.43

SBRA

Hold

43

out of 100

Grade: D

Growth: 5.3Profit: 3.5Value: 4.7Quality: 5.5
Piotroski: 3/9Altman Z: 0.39
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CUBEUndervalued (+27.0%)

Margin of Safety

+27.0%

Fair Value

$52.92

Current Price

$39.54

$13.38 discount

UndervaluedFair: $52.92Overvalued
SBRAUndervalued (+84.4%)

Margin of Safety

+84.4%

Fair Value

$125.35

Current Price

$20.52

$104.83 discount

UndervaluedFair: $125.35Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CUBE2 strengths · Avg: 9.5/10
Operating MarginProfitability
41.1%10/10

Strong operational efficiency at 41.1%

Profit MarginProfitability
29.3%9/10

Keeps 29 of every $100 in revenue as profit

SBRA2 strengths · Avg: 8.0/10
Price/BookValuation
1.9x8/10

Reasonable price relative to book value

Revenue GrowthGrowth
25.3%8/10

Revenue surging 25.3% year-over-year

Areas to Watch

CUBE4 concerns · Avg: 3.5/10
P/E RatioValuation
26.9x4/10

Moderate valuation

Revenue GrowthGrowth
1.5%4/10

1.5% revenue growth

Debt/EquityHealth
1.373/10

Elevated debt levels

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

SBRA4 concerns · Avg: 2.8/10
Return on EquityProfitability
5.6%3/10

ROE of 5.6% — below average capital efficiency

Profit MarginProfitability
7.6%3/10

7.6% margin — thin

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

PEG RatioValuation
5.282/10

Expensive relative to growth rate

Comparative Analysis Report

WallStSmart Research

Bull Case : CUBE

The strongest argument for CUBE centers on Operating Margin, Profit Margin. Profitability is solid with margins at 29.3% and operating margin at 41.1%.

Bull Case : SBRA

The strongest argument for SBRA centers on Price/Book, Revenue Growth. Revenue growth of 25.3% demonstrates continued momentum.

Bear Case : CUBE

The primary concerns for CUBE are P/E Ratio, Revenue Growth, Debt/Equity.

Bear Case : SBRA

The primary concerns for SBRA are Return on Equity, Profit Margin, Piotroski F-Score. A P/E of 80.0x leaves little room for execution misses.

Key Dynamics to Monitor

CUBE profiles as a value stock while SBRA is a growth play — different risk/reward profiles.

CUBE carries more volatility with a beta of 1.05 — expect wider price swings.

SBRA is growing revenue faster at 25.3% — sustainability is the question.

CUBE generates stronger free cash flow (109M), providing more financial flexibility.

Bottom Line

CUBE scores higher overall (56/100 vs 43/100), backed by strong 29.3% margins. SBRA offers better value entry with a 84.4% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

CubeSmart

REAL ESTATE · REIT - INDUSTRIAL · USA

CubeSmart is a self-managed and self-managed real estate investment trust.

Visit Website →

Sabra Healthcare REIT Inc

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

As of September 30, 2020, Sabra's investment portfolio included 425 real estate properties held for investment (consisting of (i) 287 skilled nursing / transitional care facilities, (ii) 64 senior housing communities (?

Want to dig deeper into these stocks?